Show simple item record

dc.contributor.authorKahraman, Resul
dc.contributor.authorSinem İplik, Elif
dc.contributor.authorCalhan, Turan
dc.contributor.authorŞahin, Abdurrahman
dc.contributor.authorÇakmakoğlu, Bedia
dc.date.accessioned2021-12-21T08:32:07Z
dc.date.available2021-12-21T08:32:07Z
dc.date.issued2018
dc.identifier.issn2564-6567
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TWpreU9EYzBOQT09/assessment-of-the-role-of-egf-61a-g-and-egfr-r497k-polymorphism-in-patients-with-inflammatory-bowel-disease-a-case-control-study
dc.identifier.urihttps://doi.org/10.25000/acem.416704
dc.identifier.urihttp://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/948
dc.description.abstractAim: Epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) play an important role in theregulation of cell growth, survival, migration, apoptosis, proliferation, and differentiation. We aimed toinvestigate the presence of EGF (+61A/G)
dc.description.abstractAmaç: Epidermal büyüme faktörü (EGF) ve epidermal büyüme faktörü reseptörü (EGFR), hücre büyümesi, canlılığı, migrasyonu, apoptoz, proliferasyon ve farklılaşmasının düzenlenmesinde önemli bir rol oynamaktadır. İnflamatuar barsak hastalığı (İBH) olan hasta
dc.language.isoEnglish
dc.titleAssessment of the role of EGF +61A/G and EGFR R497K polymorphism in patients with inflammatory bowel disease: A case-control study
dc.title.alternativeİnflamatuar bağırsak hastalığında EGF +61A/G ve EGFR R497K polimorfizm rolünün değerlendirilmesi: Bir olgu-kontrol çalışması
dc.relation.journalArchives of Clinical and Experimental Medicine
dc.identifier.issue2
dc.identifier.startpage79
dc.identifier.endpage83
dc.identifier.volume3
dc.identifier.doi10.25000/acem.416704
dc.relation.issue2
dc.relation.volume3


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record